Chronic Trypanosoma cruzi-elicited cardiomyopathy: From the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 226-235

  Lannes Vieira, Joseli ^a   Silverio, Jaline Coutinho ^a   Pereira, Isabela Resende ^a   Vinagre, Nathália Ferreira ^a   Carvalho, Cristiano Marcelo Espinola ^a   Paiva, Cláudia Neto ^b   da Silva, Andréa Alice ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cardiomyopathy; Cell adhesion molecules; Chagas disease; Chemokine; Chemokine receptors; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 68949215972     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900029     Document Type: Article

References (74)

1. Abram CL, Lowell CA 2009. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 27: 339-362.
2. Aliberti JC, Machado FS, Souto JT, Campanelli AP, Teixeira MM, Gazzinelli RT, Silva JS 1999. beta-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun 67: 4819-4826.
3. Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, Farber J, Gazzinelli RT, Silva JS 2001. Modulation of chemokine production and inflammatory responses in interferon-gammaand tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
4. Benvenuti LA, Higuchi ML, Reis MM 2000. Upregulation of adhesion molecules and class I HLA in the myocardium of chronic chagasic cardiomyopathy and heart allograft rejection, but not in dilated cardiomyopathy. Cardiovasc Pathol 9: 111-117.
5. Bromley SK, Mempel TR, Luster AD 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol 9: 970-980.
6. Butcher EC 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
7. Calzada JE, Nieto A, Beraún Y, Martín J 2001. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 58: 154-158.
8. Carvalho CM, Andrade MC, Xavier SS, Mangia RH, Britto CC, Jansen AM, Fernandes O, Lannes-Vieira J, Bonecini-Almeida MG 2003. Chronic Chagas' disease in rhesus monkeys (Macaca mulatta): evaluation of parasitemia, serology, electrocardiography, echocardiography, and radiology. Am J Trop Med Hyg 68: 683-691.
9. Chagas C 1909. Nova tripanosomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.g., n.sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz 1: 159-218.
10. Chagas C 1911. Nova entidade morbida do homem: rezumo geral de estudos etiolojicos e clinicos. Mem Inst Oswaldo Cruz 3: 219-275.
11. Chagas C 1916. Processos patojenicos da tripanozomiase americana. Mem Inst Oswaldo Cruz 8: 5-35.
12. Chagas C, Villela E 1922. Cardiac form of American trypanosomiasis. Mem Inst Oswaldo Cruz 14: 3-54.
13. Coura JR 2007. Chagas disease: what is known and what is needed a background article. Mem Inst Oswaldo Cruz 102: 113-122.
14. +lymphocytes. Am J Trop Med Hyg 48: 637-644.
15. Dias JC 2007. Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation and perspectives. Mem Inst Oswaldo Cruz 102: 11-18.
16. High) activation phenotype and expression of IFN-gammainducible adhesion and chemoattractant molecules. Microbes Infect 3: 971-984.
17. Durand JL, Tang B, Gutstein DE, Petkova S, Teixeira MM, Tanowitz HB, Jelicks LA 2006. Dyskinesis in chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. Magn Reson Imaging 24: 1051-1057.
18. Fernández-Mestre MT, Montagnani S, Layrisse Z 2004. Is the CCR559029-G/G genotype a protective factor for cardiomyopathy in Chagas disease? Hum Immunol 65: 725-728.
19. Filippatos GS, Kardaras F 2002. Chemokines and other novel inflammatory markers in hypertension: what can their plasma levels tell us? Int J Cardiol 83: 21-23.
20. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correa-Oliveira R 2005. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960-7966.
21. Hardison JL, Kuziel WA, Manning JE, Lane TE 2006a. Chemokine CC receptor 2 is important for acute control of cardiac parasitism but does not contribute to cardiac inflammation after infection with Trypanosoma cruzi. J Infect Dis 193: 1584-1588.
22. Hardison JL, Wrightsman RA, Carpenter PM, Kuziel WA, Lane TE, Manning JE 2006b. The CC chemokine receptor 5 is important in control of parasite replication and acute cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74: 135-143.
23. Hardison JL, Wrightsman RA, Carpenter PM, Lane TE, Manning JE 2006c. The chemokines CXCL9 and CXCL10 promote a protective immune response but do not contribute to cardiac inflammation following infection with Trypanosoma cruzi. Infect Immun 74: 125-134
24. +T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
25. Higuchi M de L, Benvenuti LA, Martins Reis M, Metzger M 2003. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96-107.
26. Higuchi M de L, Gutierrez PS, Aiello VD, Palomino S, Bocchi E, Kalil J, Bellotti G, Pileggi F 1993. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 423: 157-160.
27. Horuk R 2009. Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov 8: 23-33.
28. Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, Wittner M, Tanowitz HB 1999. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun 67: 5434-5440.
29. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
30. Kierszenbaum F 1985. Is there autoimmunity in Chagas disease? Parasitol Today 1: 4-6.
31. Kierszenbaum F 2005. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 21: 513-516.
32. +T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNFalpha blockade. Mem Inst Oswaldo Cruz 103: 375-385.
33. Kummer C, Ginsberg MH 2006. New approaches to blockade of alpha4-integrins, proven therapeutic targets in chronic inflammation. Biochem Pharmacol 72: 1460-1468.
34. +T cell-mediated myocarditis: chemokine receptors and adhesion molecules as potential therapeutic targets to control chronic inflammation? Mem Inst Oswaldo Cruz 98: 299-304.
35. Laranja FS, Dias E, Nobrega GC, Miranda A 1956. Chagas' disease. A clinical, epidemiologic and pathologic study. Circulation 14: 1035-1060.
36. Laranja FS, Dias E, Pellegrino J 1950. Chagas' heart disease: a cardiological entity, Resumes de Ier Congress Mondial de Cardiologie, Paris, p. 302.
37. Laucella S, De Titto EH, Segura EL, Orn A, Rottenberg ME 1996a. Soluble cell adhesion molecules in human Chagas' disease: association with disease severity and stage of infection. Am J Trop Med Hyg 55: 629-634.
38. Laucella S, Salcedo R, Castaños-Velez E, Riarte A, De Titto EH, Patarroyo M, Orn A, Rottenberg ME 1996b. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunol 18: 227-239.
39. Laucella SA, Segura EL, Riarte A, Sosa ES 1999. Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease. Clin Exp Immunol 118: 423-427.
40. Ley K, Laudanna C, Cybulsky MI, Nourshargh S 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
41. Lima MF, Zhang Y, Villalta F 1997. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell Mol Biol 43: 1067-1076.
42. Luo BH, Carman CV, Springer TA 2007. Structural basis of integrin regulation and signaling. Annu Rev Immunol 25: 619-647.
43. Machado FS, Koyama NS, Carregaro V, Ferreira BR, Milanezi CM, Teixeira MM, Rossi MA, Silva JS 2005. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 191: 627-636.
44. Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS 2000. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxidedependent trypanocidal activity. Circulation 102: 3003-3008.
45. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S 2008. BENEFIT Investigators Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156: 37-43.
46. Marino AP, Azevedo MI, Lannes-Vieira J 2003. Differential expression of adhesion molecules shaping the T-cell subset prevalence during the early phase of autoimmune and Trypanosoma cruzielicited myocarditis. Mem Inst Oswaldo Cruz 98: 945-952.
47. Marino AP, da Silva A, dos Santos P, Pinto LM, Gazzinelli RT, Teixeira MM, Lannes-Vieira J 2004. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (MetRANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 110: 1443-1449.
48. Medeiros GA, Silvério JC, Marino AP, Roffê E, Vieira V, Kroll-Palhares K, Carvalho CE, Silva AA, Teixeira MM, Lannes-Vieira J 2009. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. Microbes Infect 11: 264-273.
49. Melo RC, Brener Z 1978. Tissue tropism of different Trypanosoma cruzi strains. J Parasitol 64: 475-482.
50. Michailowsky V, Celes MR, Marino AP, Silva AA, Vieira LQ, Rossi MA, Gazzinelli RT, Lannes-Vieira J, Silva JS 2004. Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi. J Immunol 173: 463-470.
51. Petray P, Corral R, Meckert P, Laguens R 2002. Role of macrophage inflammatory protein-1alpha (MIP-1alpha) in macrophage homing in the spleen and heart pathology during experimental infection with Trypanosoma cruzi. Acta Trop 83: 205-211.
52. Proudfoot AE 2002. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2: 106-115.
53. Ramasawmy R, Cunha-Neto E, Fae KC, Martello FG, Müller NG, Cavalcanti VL, Ianni B, Mady C, Kalil J, Goldberg AC 2006. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis 43: 305-311.
54. +lymphocytes. Am J Trop Med Hyg 48: 637-644.
55. +in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosomacruzi antigens. Clin Immunol Immunopathol 83: 165-172.
56. Ribeiro Dos Santos R, Hudson L 1980. Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Clin Exp Immunol 40: 36-41.
57. ++T-cell-mediated Trypanosoma cruzi-elicited meningoencephalitis. J Neuroimmunol 142: 17-30.
58. Roffê E, Souza AL, Caetano BC, Machado PP, Barcelos LS, Russo RC, Santiago HC, Souza DG, Pinho V, Tanowitz HB, Camargos ER, Bruña-Romero O, Teixeira MM 2006. A DNA vaccine encoding CCL4/MIP-1beta enhances myocarditis in experimental Trypanosoma cruzi infection in rats. Microbes Infect 8: 2745-2755.
59. +T lymphocytes. J Immunol 167: 181-187.
60. Santos-Buch CA, Teixeira AR 1974. The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro. J Exp Med 140: 38-53.
61. Schmunis GA 2007. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 102: 75-85.
62. Sigmundsdottir H, Butcher EC 2008. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 9: 981-987.
63. Silva AA, Roffê E, Santiago H, Marino AP, Kroll-Palhares K, Teixeira MM, Gazzinelli RT, Lannes-Vieira J 2007. Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process. J Neuroimmunol 184: 156-163.
64. Silverio JC, Pinto LMO, Silva AA, Oliveira GO, Lannes-Vieira J 2009. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection. Int J Exp Pathol, in press.
65. Soares MBP, Ribeiro dos Santos R 2009. Current status and perspectives of cell therapy in Chagas disease. Mem Inst Oswaldo Cruz 104: COMPLETAR NA PAGINAÇÃO.??
66. Soeiro MN, de Castro SL 2009. Trypanosoma cruzi targets for new chemotherapeutic approaches. Expert Opin Ther Targets 13: 105-121.
67. Springer TA 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57: 827-872.
68. Talvani A, Ribeiro CS, Aliberti JC, Michailowsky V, Santos PV, Murta SM, Romanha AJ, Almeida IC, Farber J, Lannes-Vieira J, Silva JS, Gazzinelli RT 2000. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2: 851-866.
69. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM 2004a. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950.
70. Talvani A, Rocha MO, Ribeiro AL, Correa-Oliveira R, Teixeira MM 2004b. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis 189: 214-220.
71. Tarleton RL, Zhang L, Downs MO 1997. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci USA 94: 3932-3937.
72. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF 1998. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 66: 4690-4695.
73. Viola A, Luster AD 2008. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 48: 171-197.
74. Yamauchi LM, Aliberti JC, Baruffi MD, Portela RW, Rossi MA, Gazzinelli RT, Mineo JR, Silva JS 2006. The binding of CCL2 to the surface of Trypanosoma cruzi induces chemo-attraction and morphogenesis. Microbes Infect 9: 111-118.